Oppenheimer Maintains Outperform on Pharvaris, Raises Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Justin Kim maintains an Outperform rating on Pharvaris (NASDAQ:PHVS) and raises the price target from $36 to $38.
July 03, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Justin Kim maintains an Outperform rating on Pharvaris and raises the price target from $36 to $38.
The raised price target and maintained Outperform rating from a reputable analyst at Oppenheimer is likely to boost investor confidence in Pharvaris, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100